175pxls.gif (835 bytes)
Click here to return to ‘trade topics’

TRIPS : WHO/WTO WORKSHOP ON DRUG PRICING AND FINANCING, HØSBJØR 2001
Participants

As on 6 April 2001. The workshop was 8–11 April 2001

175pxls.gif (835 bytes)
More information


Applebaum, Harvey    Covington & Burling
Balasubramaniam, K    Consumers International
Bale, Harvey    IFPMA — International Federation of Pharmaceutical Manufacturers Associations
Bayer, Ron    Columbia University
Berkley, Seth    IAVI – International AIDS Vaccine Initiative
Bisonga, John    Customs and Excise Department, Kenya
Bloomer, Phil    Oxfam
Chidyausiku, Boniface    Zimbabwe
Cleves, Julia    UNAIDS
Correa, Carlos    University of Buenos Aires
Danzon, Patricia    Wharton School, University of Pennsylvania (Videoconference)
Faber, Gunter    GlaxoSmithKline
Fleet, Julian    UNAIDS
Fransen, Lieve    European Commission
Haddad, Bill    CIPLA; U.S. Research and Development Corporation
Hardwick, Chuck    Pfizer, Inc.
Harper, Malaya    UK DFID
Harrington, Mark     Treatment Coalition
Heimler, Alberto Autorita    Garante della Concorrenza e del Mercato
Henry, David    Newcastle University, Australia
Hessou, Pascal    ACAME
Hoekman, Bernard   World Bank
Itschner, Albert    Novartis
Johns, Desmond    South African Government
Jorge, Fabiana Latin American Generic Association
Kadama, Patrick    Ministry of Health, Uganda
Laing, Richard    Boston University
Love, Jamie    Consumer Project on Technology
McCullough, Keith    Vuna Healthcare Logistics
Martin, Jacques-François    Global Fund for Children's Vaccines
Medlin, Carol    Institute for Global Health
Miles, Cecile    Ranbaxy
Nightingale, Stuart    US DHHS
Ochola, Dorothy    Uganda Improved Access to HIV/AIDS Drugs
Papovich, Joe    US Trade Representative
Pedersen, Hanne    UNICEF
Piot, Peter    UNAIDS
Redwood, Heinz    Author and Industry Consultant
Rovira, Joan    World Bank
Sachs, Jeffrey    Harvard University (Videoconference)
Saunders, Christian    UNFPA
Scherer, Mike    Harvard University
Schoonveld, Ed    Cambridge Pharma Consultancy
So, Anthony    Rockefeller Foundation
Speaker, Mark    Bristol-Myers Squibb Co.
Steiger, William    US DHHS
Stenvik, Are    Oslo University
Sturchio, Jeffrey    Merck & Co., Inc.
Teixeira, Paulo    Ministry of Health, Brazil
’t Hoen, Ellen    Médecins Sans Frontières
Torongo, Mabel    International Pharmaceutical Federation
Vandoren, Paul    European Commission
Varet, Françoise    Ministry of Health, France
Wanyanga, Wilberforce    COSMOS
Wecker, John Boehringer    Ingelheim
Wibulpolprasert, Suwit    Ministry of Health, Thailand
Wilder, Richard    Powell, Goldstein, Frazer & Murphy
Wong, Clifford    Kaiser Permanente (retired); MedImpact Healthcare Systems, Inc.
Woods, Guy    Lacuna Research, Ltd.
Yamamoto, Junji    Ministry of Health, Japan



WHO

Brundtland, Gro Harlem    WHO
Creese, Andrew    WHO
Dukes, Graham    Consultant (International Journal of Risk and Safety in Medicine)
Lidén, Jon    WHO
Neira, Maria    WHO
Quick, Jonathan    WHO
Suzuki, Yasuhiro    WHO
Velasquez, German    WHO


WTO

Anderson, Robert    WTO Secretariat
Otten, Adrian    WTO Secretariat
Tran Wasescha, Thu-Lang    WTO Secretariat
Ungphakorn, Peter    WTO Secretariat
Watal, Jayashree    Consultant


Global Health Council

Daulaire, Nils    Global Health Council
Hall, Sadhana    Global Health Council
Sorensen, Karen    Global Health Council


Norway

Christiansen, Ottar    Norwegian Ministry of Foreign Affairs
Eckey, Susan    Norwegian Ministry of Foreign Affairs
Haralstad, Hilde    Norwegian Ministry of Foreign Affairs
Møgedal, Sigrun    State Secretary for International Development, Norway
Riise, Anne    Norwegian Ministry of Foreign Affairs
Sydnes, Anne Kristin    Minister for International Development, Norway
Tonseth, Didrik    Norwegian Ministry of Foreign Affairs
Walther, Arne    Norwegian Ministry of Foreign Affairs


Participants of the Press conference following the Closing of the WHO/WTO  - Hosbjor, Norway, 11 April 2001
 
 
Gro Harlem Brundtland   the Director General of the World Health Organization;
Adrian Otten   Director of the World Trade Organization’s Intellectual Property Division;
Sigrunn Møgedal   State Secretary of the Ministry of Foreign Affairs of Norway
Nils Daulaire   President of the Global Health Council.
Lieve Fransen  Head of the Social Development Unit, Development Department of the European Commission;
Harvey Bale   Director-General of the International Federation of Pharmaceutical Manufacturers’ Associations;
Ellen t’Hoen   Coordinator for Médecins Sans Frontières’ Access to Essential Medicines Campaign.